Myocardial perfusion reserve in spared myocardium: Correlation with infarct size and left ventricular ejection fraction

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 40, Issue 8, 2013, Pages 1148-1154

  Juárez Orozco, Luis Eduardo ^a,b   Glauche, Julius ^a   Alexanderson, Erick ^b,d   Zeebregts, Clark J ^a   Boersma, Hendrikus H ^a   Glaudemans, Andor W J M ^a   Dierckx, Rudi A ^a,c   Van Veldhuisen, Dirk J ^a   Tio, René A ^a   Slart, Riemer H J A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Infarct size; Left ventricular ejection fraction; Myocardial perfusion reserve; Spared myocardium

Indexed keywords

ACETYLSALICYLIC ACID; ACIPIMOX; AMMONIA N 13; DIPYRIDAMOLE; FLUORODEOXYGLUCOSE F 18; NEDIOS; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; DRUG BLOOD LEVEL; DRUG ERUPTION; DRUG HALF LIFE; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION RESERVE; PET SCANNER; PHARMACOLOGIC STRESS TESTING; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REST; RISK FACTOR; STRESS;

AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HEART; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL PERFUSION IMAGING; POSITRON-EMISSION TOMOGRAPHY; STROKE VOLUME; VENTRICULAR DYSFUNCTION;

EID: 84879989391     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-013-2394-y     Document Type: Article

References (24)

1. Mahon NG, O'Rorke C, Codd MB, McCann HA, McGarry K, Sugrue DD. Hospital mortality of acute myocardial infarction in the thrombolytic era. Heart 1999;81(5):478-82.
2. Tio RA, Dabeshlim A, Siebelink HM, de Sutter J, Hillege HL, Zeebregts CJ, et al. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med 2009;50(2):214-9.
3. Tio RA, Slart RH, de Boer RA, van der Vleuten PA, de Jong RM, van Wijk LM, et al. Reduced regional myocardial perfusion reserve is associated with impaired contractile performance in idiopathic dilated cardiomyopathy. Neth Heart J 2009;17(12):470-4.
4. van den Heuvel AF, van Veldhuisen DJ, van der Wall EE, Blanksma PK, Siebelink HM, Vaalburg WM, et al. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2000;35(1):19-28.
5. de Boer RA, Pinto YM, van Veldhuisen DJ. The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities. Microcirculation 2003;10(2):113-26.
6. van Veldhuisen DJ, van den Heuvel AF, Blanksma PK, Crijns HJ. Ischemia and left ventricular dysfunction: a reciprocal relation? J Cardiovasc Pharmacol 1998;32 Suppl 1:S46-51.
7. Slart RH, Zeebregts CJ, Hillege HL, de Sutter J, Dierckx RA, van Veldhuisen DJ, et al. Myocardial perfusion reserve after a PET-driven revascularization procedure: a strong prognostic factor. J Nucl Med 2011;52(6):873-9.
8. Vatner SF, Hittinger L. Myocardial perfusion dependent and independent mechanisms of regional myocardial dysfunction in hypertrophy. Basic Res Cardiol 1993;88 Suppl 1:81-95.
9. Vatner SF, Hittinger L. Coronary vascular mechanisms involved in decompensation from hypertrophy to heart failure. J Am Coll Cardiol 1993;22(4 Suppl A):34A-40.
10. Pride YB, Giuseffi JL, Mohanavelu S, Harrigan CJ, Manning WJ, Gibson CM, et al. Relation between infarct size in ST-segment elevation myocardial infarction treated successfully by percutaneous coronary intervention and left ventricular ejection fraction three months after the infarct. Am J Cardiol 2010;106(5):635-40.
11. Knuuti MJ, Yki-Järvinen H, Voipio-Pulkki LM, Mäki M, Ruotsalainen U, Härkönen R, et al. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative. J Nucl Med 1994;35(6):989-98.
12. Knuuti MJ, Nuutila P, Ruotsalainen U, Saraste M, Härkönen R, Ahonen A, et al. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med 1992;33(7):1255-62.
13. Blanksma PK, Willemsen ATM, Meeder JG, de Jong RM, Anthonio RL, Pruim J, et al. Quantitative myocardial mapping of perfusion and metabolism using parametric polar map displays in cardiac PET. J Nucl Med 1995;36(1):153-8.
14. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990;15(5):1032-42.
15. Gambhir SS, Schwaiger M, Huang SC, Krivokapich J, Schelbert HR, Nienaber CA, et al. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med 1989;30(3):359-66.
16. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995;36(11):2138-47.
17. Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003;349(11):1027-35.
18. Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol 1999;34(3):618-20.
19. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007;356(8):830-40.
20. Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, Pratali L, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002;105(2):186-93.
21. Fukushima K, Javadi MS, Higuchi T, Lautamäki R, Merrill J, Nekolla SG, et al. Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging. J Nucl Med 2011;52(5):726-32.
22. Velazquez EJ, Lee KL, O'Connor CM, Oh JK, Bonow RO, Pohost GM, et al. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg 2007;134(6):1540-7.
23. Bax M, de Winter RJ, Schotborgh CE, Koch KT, Meuwissen M, Voskuil M, et al. Short- and long-term recovery of left ventricular function predicted at the time of primary percutaneous coronary intervention in anterior myocardial infarction. J Am Coll Cardiol 2004;43(4):534-41.
24. Prati F, Petronio S, van Boven AJ, Tendera M, De Luca L, de Belder MA, et al. Evaluation of infarct-related coronary artery patency and microcirculatory function after facilitated percutaneous primary coronary angioplasty: the FINESSE-ANGIO (Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events-Angiographic) study. JACC Cardiovasc Interv 2010;3(12):1284-91.